Correlation Between Nasdaq 100 and Biotechnology Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nasdaq 100 and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nasdaq 100 and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nasdaq 100 2x Strategy and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Nasdaq 100 and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nasdaq 100 with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nasdaq 100 and Biotechnology Ultrasector.

Diversification Opportunities for Nasdaq 100 and Biotechnology Ultrasector

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nasdaq and Biotechnology is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Nasdaq 100 2x Strategy and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Nasdaq 100 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nasdaq 100 2x Strategy are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Nasdaq 100 i.e., Nasdaq 100 and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Nasdaq 100 and Biotechnology Ultrasector

Assuming the 90 days horizon Nasdaq 100 2x Strategy is expected to generate 0.69 times more return on investment than Biotechnology Ultrasector. However, Nasdaq 100 2x Strategy is 1.45 times less risky than Biotechnology Ultrasector. It trades about 0.34 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.07 per unit of risk. If you would invest  43,534  in Nasdaq 100 2x Strategy on April 24, 2025 and sell it today you would earn a total of  18,722  from holding Nasdaq 100 2x Strategy or generate 43.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Nasdaq 100 2x Strategy  vs.  Biotechnology Ultrasector Prof

 Performance 
       Timeline  
Nasdaq 100 2x 

Risk-Adjusted Performance

Strong

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nasdaq 100 2x Strategy are ranked lower than 26 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Nasdaq 100 showed solid returns over the last few months and may actually be approaching a breakup point.
Biotechnology Ultrasector 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Biotechnology Ultrasector may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Nasdaq 100 and Biotechnology Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nasdaq 100 and Biotechnology Ultrasector

The main advantage of trading using opposite Nasdaq 100 and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nasdaq 100 position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.
The idea behind Nasdaq 100 2x Strategy and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency